Table 1 Patient clinical and pathological characteristics
Patients with Breast Cancer | N = 200 |
Age: Mean (SD) | 58.9 (11.4) |
White Race: n (%) | 193 (97%) |
BMI [kg/m2]: Mean (SD) | 29.7 (6.6) |
Smoking Status: n (%) | |
Current | 22 (11%) |
Never | 120 (60%) |
Past | 58 (29%) |
Family History Yes: n (%) | 114 (58%) |
Tumor Type: n (%) | |
Invasive | 148 (74%) |
in situ | 52 (26%) |
Tumor Max Dimension [cm]: n (%) | |
≤ 1 | 66 (36%) |
> 1 to ≤2 | 65 (35%) |
> 2 | 53 (29%) |
Histology: n (%) | |
Ductal and Lobular | 3 (2%) |
Ductal | 173 (87%) |
Lobular | 21 (11%) |
Other | 2 (1%) |
ER Positive: n (%) | 171 (86%) |
PR Positive: n (%) | 147 (74%) |
HER2 Amplification: n (%) | |
Negative | 132 (66%) |
Positive | 15 (8%) |
Unknown | 53 (27%) |
Triple Negative: n (%) | 18 (12%) |
Lymph Node Involvement: n (%) | 47 (24%) |
Matched Healthy Controls | N = 200 |
Age: Mean (SD) | 58.8 (11.3) |
White Race: n (%) | 192 (97%) |
BMI [kg/m2]: Mean (SD) | 27.1 (5.5) |
Smoking Status: n (%) | |
Current | 7 (4%) |
Never | 125 (63%) |
Past | 67 (34%) |